Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M535Revenue $M37.1Net Margin (%)-50.3Altman Z-Score7.1
Enterprise Value $M364EPS $-0.3Operating Margin %-83.0Piotroski F-Score4
P/E(ttm)--Beneish M-Score0.5Pre-tax Margin (%)-54.9Higher ROA y-yY
Price/Book2.810-y EBITDA Growth Rate %-16.8Quick Ratio10.1Cash flow > EarningsY
Price/Sales14.05-y EBITDA Growth Rate %-5.0Current Ratio10.1Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-11.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-13.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M72.2ROIC % (ttm)-139.7Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
INOFirst Eagle Investment 2014-03-31 Sold Out $9.76 - $15.28
$ 7.36-38%Sold Out0
INOFirst Eagle Investment 2013-12-31 Buy $6.92 - $11.88
$ 7.36-12%New holding62,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!

INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Sardesai NiranjanCOO 2015-09-30Buy4,000$5.534.73view
BENITO SIMON XDirector 2015-08-14Buy6,000$7.212.77view
Cabrera AngelDirector 2015-04-13Buy8,000$9.53-22.25view
KIES PETERCFO 2014-10-09Buy3,960$10.1-26.63view
COLLINS MORTONDirector 2014-08-21Buy8,000$10.01-25.97view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.74-23.92view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.06-18.21view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.7-14.83view
Kim Jong JosephCEO 2014-04-15Buy6,250$9-17.67view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.281.79view

Press Releases about INO :

Quarterly/Annual Reports about INO:

    News about INO:

    Articles On GuruFocus.com
    EG Nov 24 2015 
    EG Nov 24 2015 
    JeG Nov 24 2015 
    JeG Nov 24 2015 
    us1 Oct 12 2015 
    us1 Oct 12 2015 
    Inovio Pharmaceuticals' CEO Dr. J. Joseph Kim Interviewed by The Life Sciences Report Oct 30 2014 
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
    comment on INO May 10 2013 
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 

    More From Other Websites
    Inovio Pharmaceuticals Inc (INO): Hedge Fund Sentiment Unchanged Nov 25 2015
    Inovio Pharmaceuticals to Present at Piper Jaffray Healthcare Conference Nov 23 2015
    GeneOne Life Science and Inovio Pharmaceuticals’ MERS Vaccine Approved for First-in-Human Study Nov 19 2015
    INOVIO PHARMACEUTICALS, INC. Financials Nov 17 2015
    Can Inovio Pharmaceuticals (INO) Run Higher on Strong Earnings Estimate Revisions? Nov 17 2015
    GeneOne Life Science and the Walter Reed Army Institute of Research Partner to Develop MERS Vaccine Nov 10 2015
    Inovio's (INO) Q3 Earnings Impress, Revenues Up Y/Y Nov 10 2015
    Inovio beats 3Q profit forecasts Nov 09 2015
    Inovio beats 3Q profit forecasts Nov 09 2015
    Inovio (INO) Swings into Earnings in Q3, Revenues Miss Nov 09 2015
    Inovio Pharmaceuticals Reports 2015 Third Quarter Results Nov 09 2015
    Inovio Pharmaceuticals Reports 2015 Third Quarter Results Nov 09 2015
    INOVIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2015
    Will Inovio (INO) Disappoint Investors this Earnings Season? Nov 06 2015
    Inovio’s INO-3112 Shows Robust Immune Responses in Patients With Head & Neck Cancer Nov 05 2015
    Inovio Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : October 30,... Oct 30 2015
    Video-Taking Immunotherapy to the Next level for Inovio Pharmaceuticals, Inc. Oct 26 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)